Major cancer study aims to standardize test results across china
NCT ID NCT07404202
Summary
This study aims to see if different labs and pathologists get the same results when testing cancer tissue for the HER2 protein. Researchers will look back at tissue samples from about 2,100 Chinese patients with lung, gynecologic, bile duct, or bladder cancer. The goal is to understand how consistent these important diagnostic tests are across different hospitals and testing methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.